(b)(4).The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents from this lot.The reported patient effects of worsening mitral regurgitation, dyspnea and worsening heart failure as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.It is possible that the patient anatomy (retracted posterior leaflet, prolapsed anterior leaflet, enlarged atrium) contributed to the reported slda; however this cannot be confirmed.The reported mitral regurgitation, dyspnea, weakness (physical) and heart failure were likely the result of the slda.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
This is filed to report the single leaflet device attachment (slda).It was reported that this was a mitraclip performed on (b)(6) 2019 to treat mixed mitral regurgitation (mr) with a grade of 4+.One clip was implanted, reducing the mr to 1+.On (b)(6) 2019, the patient was hospitalized with dyspnea, weakness, worsening heart failure.Echocardiogram was performed and it was noted that the clip detached from the posterior leaflet, and remained attached to the anterior leaflet (slda) and mr increased to 4.Cardiac surgery will be performed.There was no additional information provided.
|